Sibylle Herzig van Wees
Biträdande Lektor | Docent
E-postadress: sibylle.herzig.van.wees@ki.se
Besöksadress: Widerströmska huset Tomtebodavägen 18 A, plan 3, 17165 Solna
Postadress: K9 Global folkhälsa, K9 GPH Hanson Herzig van Wees, 171 77 Stockholm
Del av:
Artiklar
- Article: GLOBAL HEALTH ACTION. 2026;19(1):2635822Berhanu W; Yigremachew S; Hanson C; Avermark H; Addissie A; Herzig Van Wees S
- Article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2026;22(1):2710533Avermark H; Strom M; van Wees SH
- Journal article: GLOBAL HEALTH ACTION. 2026;19(1):2635822Berhanu W; Yigremachew S; Hanson C; Avermark H; Addissie A; Herzig van Wees S
- Article: JOURNAL OF HEALTH POPULATION AND NUTRITION. 2026;45(1):190Gobbo E; Ojwang AA; Annerstedt KS; Amoke JO; Anyango LJ; Herzig van Wees S; Nunda D; Ouko E; Oruko E; Alvesson HM
- Article: REPRODUCTIVE HEALTH. 2026;23(1):147Wessing LE; Daraiseh S; Semmane Y; Chassioti AS; Sreenivasan A; Tirado V; Johansson EW; Gardner R; van Wees SH; Hanson C; Sun S
- Article: PLOS ONE. 2026;21(3):e0310437Sogbesan A; Bakare AA; Herzig Van Wees S; Salako J; Bakare D; Olojede OE; Akinsola K; Bakare OR; Falade AG; King C
- Article: LAKARTIDNINGEN. 2026;123:25143Herzig van Wees S; Nejat S; Mohamed F
- Article: FRONTIERS IN SOCIOLOGY. 2026;11:1762686Yohannes K; Bradby H; van Wees SH; Berhane Y; Persson-Fischier U; Målqvist M
- Article: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2025;21(1):2578894Berhanu W; Gobbo E; Herzig van Wees S; Hanson C; Addissie A
- Article: EXPERT REVIEW OF VACCINES. 2025;24(1):1137-1148Salako J; Bakare D; Akinsola KO; Bakare AA; Bakare O; Emmanuel O; Gobbo E; Hanson C; Herzig Van Wees S; Jerome A; Sanni M; Umar HI; Usman H; Zubair Sanaka J; Ahs JW; King C; Falade AG
- Article: GLOBAL PUBLIC HEALTH. 2025;20(1):2439887Gurung R; Van Wees SH
- Article: REPRODUCTIVE HEALTH. 2025;22(1):128Berglundh S; Abunnaja K; Herzig van Wees S; Larsson EC; Kilander H
- Article: FRONTIERS IN PUBLIC HEALTH. 2025;13:1563677da Cunha NM; Tzirita S; Gobbo E; van Wees SH
- Article: VACCINE. 2025;55:127020Bakare AA; Gobbo E; Akinsola KO; King C; Salako J; Bakare D; Usman H; Hanson C; Falade AG; van Wees SH
- Article: PLOS GLOBAL PUBLIC HEALTH. 2025;5(3):e0003301Berhanu W; Gobbo E; Dube AA; Megersa N; Amenu Y; Demeke M; Addisse A; Van Wees SH
- Article: FRONTIERS IN PUBLIC HEALTH. 2025;13:1488770Yohannes K; Malqvist M; Bradby H; Berhane Y; Tewahido D; van Wees SH
- Article: GLOBAL PUBLIC HEALTH. 2024;19(1):2386988Gobbo E; Dube AA; Demeke M; Berhanu W; Megersa N; Amenu Y; Addisse A; Van Wees SH
- Article: BMC PUBLIC HEALTH. 2024;24(1):3504Persson P; Hughton A; van Wees SH
- Article: BMJ GLOBAL HEALTH. 2024;9(11):e015107Agardh C; Bielik J; Ekman A-T; Velin L; van Wees SH
- Article: BMC HEALTH SERVICES RESEARCH. 2024;24(1):1325Herzig van Wees S; Kilander H; Salah K; Saidarab S; Waengborg A; Larsson EC
- Visa fler
Alla övriga publikationer
- Review: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2026;22(1):2681252Avermark H; Tzirita S; Radix E; Sun S; Herzig van Wees S
- Editorial: LANCET REGIONAL HEALTH-EUROPE. 2026;61:101586Herzig van Wees S; Kasstan-Dabush B; Deml MJ; Ibrahim IM; Mounier-Jack S; Edelstein M
- Preprint: ELSEVIER BV. 2026Wessing LE; Daraiseh S; Semmane Y; Chassioti AS; Sreenivasan A; Tirado V; Johansson E; Gardner R; Herzig van Wees S; Hanson C; Sun S
- Study protocol: BMJ OPEN. 2025;15(4):e098308Herzig van Wees S; Bakare AA; Akinsola KO; Salako J; Bakare D; Gobbo E; Hanson C; Falade AG; King C
- Review: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2024;20(1):2322796Akinsola KO; Bakare AA; Gobbo E; King C; Hanson C; Falade A; van Wees SH
- Review: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2024;20(1):2402122Bakare D; Gobbo E; Akinsola KO; Bakare AA; Salako J; Hanson C; Herzig van Wees S; Falade A; King C
- Review: HUMAN VACCINES & IMMUNOTHERAPEUTICS. 2024;20(1):2431380Alpeza F; Avermark H; Gobbo E; Herzig van Wees S
- Preprint: MEDRXIV. 2024Sogbesan A; Bakare A; van Wees SH; Salako J; Bakare D; Olojede O; Akinsola K; Bakare O; Falade A; King C
- Review: BMC PUBLIC HEALTH. 2023;23(1):2238Herzig van Wees S; Abunnaja K; Mounier-Jack S
- Review: BMC PUBLIC HEALTH. 2023;23(1):1354Gobbo ELS; Hanson C; Abunnaja KSS; van Wees SH
- Preprint: JMIR PREPRINTS. 2022Beirakdar S; Klingborg L; Herzig van Wees S
- Editorial: BMJ GLOBAL HEALTH. 2022;7(4):e008497Velin L; Van Daalen K; Guinto R; Herzig van Wees S; Saha S
- Preprint: PREPRINTS.ORG. 2020Chalermsri C; van Wees SH; Ziaei S; Ekström E-C; Muangpaisan W; Rahman SM
- Editorial: BMJ GLOBAL HEALTH. 2020;5(5):e002583Herzig van Wees S; Holmer H
- Letter: LANCET. 2020;395(10217):32van Wees SH
- Review: JOURNAL OF THE ROYAL SOCIETY OF MEDICINE. 2015;108(3):93-100Chatfield-Ball C; Boyle P; Autier P; van Wees SH; Sullivan R
Forskningsbidrag
- Swedish Research Council for Health Working Life and Welfare1 juli 2024 - 30 september 2025
- Swedish Research Council for Health Working Life and Welfare1 januari 2024 - 31 december 2027The human papillomavirus (HPV) is responsible for most cervical and anogenital cancers. The HPV vaccine can effectively reduce invasive cervical cancerhowever, HPV vaccine uptake is low in certain groups due to hesitancy and refusal, which undermines the success of the vaccine. In Sweden, HPV vaccine hesitancy has mainly been observed among parents and adolescents in socioeconomically disadvantaged communities with large immigrant populations.The purpose of this project is therefore to co-design and assess the feasibility and preliminary effects of digital health intervention tools to reduce HPV vaccine hesitancy and increase uptake of this vaccine in socioeconomically disadvantaged communities in Stockholm, Sweden. Several research questions shall assess whether a co-designed digital health intervention has the potential to improve HPV uptake, awareness and confidence.The project involves three sub-studies implemented by an interdisciplinary team. Study 1 will involve a formative stage whereby adolescents, parents/guardians and school nurses situated in socially disadvantaged areas in Stockholm will be interviewed to understand their perspectives and concerns related to the HPV vaccine. Thereafter, study 2 will use knowledge gained from study 1 to inform the co-design phase where adolescent boys/girls and their parents/guardians are invited to develop and provide feedback on content and prototypes for digital health interventions. Finally, study 3 will involve pilot-testing of the intervention for feasibility, acceptability and preliminary effect, using a cluster-randomized design.This project is highly feasible as it builds on the study team’s previous research, which show that immigrant communities in Sweden experience poorer health outcomes as well as vaccine hesitancy. Because 1 in 5 Swedes have a migrant background this study is relevant to Swedish society. An appropriate and accessible digital health intervention has the potential to prevent cervical cancer, saving lives and reducing future burdens on an overstretched Swedish healthcare system. The results from this project will be generalizable to similar contexts in Sweden and possibily beyond.
- Swedish Research Council1 januari 2023 - 31 december 2024
- Swedish Research Council1 december 2022 - 30 november 2025
- Swedish Research Council for Health Working Life and Welfare1 januari 2022 - 31 december 2024
Anställningar
- Biträdande Lektor, Global folkhälsa, Karolinska Institutet, 2023-2029
Examina och utbildning
- Docent, Global hälsa, Karolinska Institutet, 2024